双极性疾病中的辅助抗抑郁药的使用及其临床相关物:亚洲心理药物处方模式联盟研究
Yi Hu1, Qian Hui Chew2, Shih-Ku Lin3,4
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
概括
在双相情感障碍 (BD) 中,辅助抗抑郁药的使用在亚洲比在西方国家少. 这种做法与老年,抑郁和自杀行为有关,需要仔细监测.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 在全球范围内,辅助抗抑郁药 (AD) 在双相情感障碍 (BD) 治疗中很常见.
- 关于亚洲人群对BD的AD使用的数据有限.
研究的目的:
- 确定亚洲大样本BD患者中辅助AD使用的流行率,剂量和临床相关物.
主要方法:
- 这是一项涉及13个亚洲地区2114名成年BD患者的横截面研究.
- 与没有附加AD治疗的患者进行比较.
- 使用多变量逻辑回归来识别相关因素.
主要成果:
- 辅助AD使用的患病率为19.8%,平均剂量为113毫克/天.
- 相关因素包括年龄较大,门诊状态,抑郁症,自杀行为,快速循环,以及较低剂量的情绪稳定剂和抗精神病药物.
- 在西方的样本中,AD的使用率不到西方样本中报告的的一半.
结论:
- 在亚洲,用于BD的辅助AD使用率低于西方国家.
- 这种做法似乎被很好地容忍,但需要对潜在的情绪或行为提升进行密切的临床监测.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
193
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.9K
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
380
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
380
Antidepressant Drugs: Overview
804
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
804
Mania and Antimanic Drugs: Overview
330
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
330
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
626
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
626
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Psychosis: Goals of Pharmacotherapy
216
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
216
